Home » Newsletters » BioWorld Science

BioWorld Science

July 19, 2017

View Archived Issues

Fosun Pharma reports Chinese IND application for FCN-437c

Phase III results for emicizumab prophylaxis in patients with hemophilia A with inhibitors presented

Nektar reports topline data from human abuse potential study of NKTR-181

Amgen and Array collaborate on discovery and development of drugs for autoimmune disorders

NT-219 enhances Keytruda activity in preclinical immuno-oncology model

Centrexion updates progress of chronic pain programs

Roche and Genentech present IRAK-4 inhibitors

Abeona receives guidance on phase III trial of EB-101 for epidermolysis bullosa

Gruenenthal identifies PDE4B inhibitors

Dompe Farmaceutici divulges TRPM8 antagonists

OncoTherapy Science and DC Vaccine Consortium partner on dendritic cell-based cancer immunotherapy

Chiesi Farmaceutici patents MAPK inhibitors

European Commission approves Reagila for schizophrenia

FDA designates StrataGraft a regenerative medicine advanced therapy

FDA grants rare pediatric disease designation to CAP-1002 for the treatment of DMD

FDA approves Vosevi for re-treatment of chronic HCV infection

Pleiotrophin identified as a novel biomarker for Alzheimer's disease

Helix BioPharma and Moffitt Cancer Center partner on L-DOS47 research studies

Adimab to transfer platform to Lilly for antibody discovery and optimization

Novartis reviews highlights of second quarter 2017

Shire and Novimmune sign license agreement for bispecific antibody for hemophilia A

Invenra and Merck & Co. collaborate on therapeutic antibody discovery

Polymorphisms in FCN3 gene tied to pemphigus foliaceous

Zymeworks and Daiichi Sankyo announce research milestone in bispecific antibody collaboration

ViraCyte exercises option to Baylor's T-cell immunotherapies targeting viruses

ElsaLys and DKFZ begin preclinical development of ELB-021 in B-cell leukemia

CMX-2043 may ameliorate clinical outcome after traumatic brain injury

Prana collaborates with Takeda on PBT-434 for Parkinson's disease gastrointestinal neuropathology

PreveCeutical enters research and option agreement with UniQuest in diabetes and obesity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 24, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026